{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:45:17Z","timestamp":1754145917475,"version":"3.41.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-01644-5","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T17:41:52Z","timestamp":1752774112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Green spectrofluorimetric method for quantification of sodium oxybate in pharmaceutical and plasma samples"],"prefix":"10.1038","volume":"15","author":[{"given":"Reem M.","family":"Alnemari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farooq M.","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneef M.","family":"Aldhafeeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maram H.","family":"Abduljabbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami M.","family":"Alzhrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf S.","family":"Althobaiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musaad M.","family":"Althobaiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif","family":"Ramzy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atiah H.","family":"Almalki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"1644_CR1","doi-asserted-by":"publisher","first-page":"272","DOI":"10.2174\/1570159X19666210407151227","volume":"20","author":"M Mamelak","year":"2022","unstructured":"Mamelak, M. Sleep, narcolepsy, and sodium oxybate. Curr. Neuropharmacol. 20, 272\u2013291. https:\/\/doi.org\/10.2174\/1570159X19666210407151227 (2022).","journal-title":"Curr. Neuropharmacol."},{"key":"1644_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40263-019-00689-1","volume":"34","author":"MJ Thorpy","year":"2020","unstructured":"Thorpy, M. J. Recently approved and upcoming treatments for narcolepsy. CNS Drugs. 34, 9\u201327. https:\/\/doi.org\/10.1007\/s40263-019-00689-1 (2020).","journal-title":"CNS Drugs"},{"key":"1644_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-3-030-33404-8_13","volume-title":"Absolute Addiction Psychiatry Review","author":"M Khan","year":"2020","unstructured":"Khan, M. & Thomas, A. Steroids, dissociatives, club drugs, inhalants, and hallucinogens. In Absolute Addiction Psychiatry Review (ed. Marienfeld, C.) 205\u2013230 (Springer, 2020). https:\/\/doi.org\/10.1007\/978-3-030-33404-8_13."},{"key":"1644_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/SAR.S315720","volume":"13","author":"E Tay","year":"2022","unstructured":"Tay, E., Lo, W. K. W. & Murnion, B. Current insights on the impact of gamma-hydroxybutyrate (GHB) abuse. Subst. Abuse Rehabil. 13, 13\u201323. https:\/\/doi.org\/10.2147\/SAR.S315720 (2022).","journal-title":"Subst. Abuse Rehabil."},{"key":"1644_CR5","unstructured":"U.S. Food and Drug Administration. Xyrem (sodium oxybate) prescribing information (2022). Retrieved from:\u00a0https:\/\/www.accessdata.fda.gov."},{"key":"1644_CR6","unstructured":"FDA Controlled Substances Staff. Regulatory control of gamma-hydroxybutyrate (GHB) and its analogs. U.S. FDA. (2020)."},{"key":"1644_CR7","unstructured":"European Medicines Agency (EMA). Sodium Oxybate Assessment Report for Narcolepsy Treatment. (2022). Retrieved from: https:\/\/www.ema.europa.eu."},{"key":"1644_CR8","unstructured":"EMA. Guidelines on bioanalytical method validation. (2023)."},{"key":"1644_CR9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00216-011-4760-6","volume":"400","author":"MR Meyer","year":"2011","unstructured":"Meyer, M. R., Weber, A. A. & Maurer, H. H. A validated GC-MS procedure for fast, simple, and cost-effective quantification of glycols and GHB in human plasma and their identification in urine and plasma developed for emergency toxicology. Anal. Bioanal. Chem. 400, 411\u2013414. https:\/\/doi.org\/10.1007\/s00216-011-4760-6 (2011).","journal-title":"Anal. Bioanal. Chem."},{"key":"1644_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.chroma.2013.04.023","volume":"1296","author":"ASM Ingels","year":"2013","unstructured":"Ingels, A. S. M., Neels, H., Lambert, W. E. & Stove, C. P. Determination of gamma-hydroxybutyric acid in biofluids using a one-step procedure with in-vial derivatization and headspace-trap gas chromatography\u2013mass spectrometry. J. Chromatogr. A 1296, 84\u201392. https:\/\/doi.org\/10.1016\/j.chroma.2013.04.023 (2013).","journal-title":"J. Chromatogr. A"},{"key":"1644_CR11","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1016\/j.chroma.2009.03.011","volume":"1216","author":"D Lenz","year":"2009","unstructured":"Lenz, D., Kr\u00f6ner, L. & Rothschild, M. A. Determination of gamma-hydroxybutyric acid in serum and urine by headspace solid-phase dynamic extraction combined with gas chromatography\u2013positive chemical ionization mass spectrometry. J. Chromatogr. A. 1216, 4090\u20134096. https:\/\/doi.org\/10.1016\/j.chroma.2009.03.011 (2009).","journal-title":"J. Chromatogr. A"},{"key":"1644_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jpba.2015.10.036","volume":"118","author":"F Vaiano","year":"2016","unstructured":"Vaiano, F. et al. Determination of endogenous concentration of \u03b3-hydroxybutyric acid (GHB) in hair through an ad hoc GC\u2013MS analysis: A study on a wide population and influence of gender and age. J. Pharm. Biomed. Anal. 118, 161\u2013166. https:\/\/doi.org\/10.1016\/j.jpba.2015.10.036 (2016).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"1644_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1556-4029.2007.00392.x","volume":"52","author":"JW Mercer","year":"2007","unstructured":"Mercer, J. W., Oldfield, L. S., Hoffman, K. N., Shakleya, D. M. & Bell, S. C. Comparative analysis of gamma-hydroxybutyrate and gamma\u2010hydroxyvalerate using GC\/MS and HPLC. J. Forensic Sci. 52, 383\u2013388. https:\/\/doi.org\/10.1111\/j.1556-4029.2007.00392.x (2007).","journal-title":"J. Forensic Sci."},{"key":"1644_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/dta.3798","author":"M Blanco-Ces","year":"2024","unstructured":"Blanco-Ces, M. et al. Rapid analytical method for quantification of Gamma\u2010Hydroxybutyrate (GHB) in hair by UPLC\u2010MS\/MS. Drug Test. Anal. https:\/\/doi.org\/10.1002\/dta.3798 (2024).","journal-title":"Drug Test. Anal."},{"key":"1644_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jpba.2017.01.022","volume":"137","author":"FP Busard\u00f2","year":"2017","unstructured":"Busard\u00f2, F. P. et al. Ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC\u2013MS\/MS) for determination of GHB, precursors and metabolites in different specimens: application to clinical and forensic cases. J. Pharm. Biomed. Anal. 137, 123\u2013131. https:\/\/doi.org\/10.1016\/j.jpba.2017.01.022 (2017).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"1644_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.forsciint.2017.01.015","volume":"274","author":"R Tittarelli","year":"2017","unstructured":"Tittarelli, R. et al. Ultra-high-performance liquid chromatography tandem mass spectrometry determination of GHB, GHB-glucuronide in plasma and cerebrospinal fluid of narcoleptic patients under sodium oxybate treatment. Forensic Sci. Int. 274, 70\u201374. https:\/\/doi.org\/10.1016\/j.forsciint.2017.01.015 (2017).","journal-title":"Forensic Sci. Int."},{"key":"1644_CR17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.talanta.2007.11.019","volume":"75","author":"CK Zacharis","year":"2008","unstructured":"Zacharis, C. K., Raikos, N., Giouvalakis, N., Tsoukali-Papadopoulou, H. & Theodoridis, G. A. A new method for the HPLC determination of gamma-hydroxybutyric acid (GHB) following derivatization with a coumarin analogue and fluorescence detection: Application in the analysis of biological fluids. Talanta 75, 356\u2013361. https:\/\/doi.org\/10.1016\/j.talanta.2007.11.019 (2008).","journal-title":"Talanta"},{"key":"1644_CR18","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.snb.2017.10.142","volume":"256","author":"R Jim\u00e9nez-P\u00e9rez","year":"2018","unstructured":"Jim\u00e9nez-P\u00e9rez, R., Sevilla, J. M., Pineda, T., Bl\u00e1zquez, M. & Gonzalez-Rodriguez, J. Electrocatalytic performance enhanced of the electrooxidation of gamma-hydroxybutyric acid (GHB) and ethanol on platinum nanoparticles surface. A contribution to the analytical determination of GHB in the presence of ethanol. Sens. Actuators B. 256, 553\u2013563. https:\/\/doi.org\/10.1016\/j.snb.2017.10.142 (2018).","journal-title":"Sens. Actuators B"},{"key":"1644_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jelechem.2016.02.005","volume":"766","author":"R Jim\u00e9nez-P\u00e9rez","year":"2016","unstructured":"Jim\u00e9nez-P\u00e9rez, R., Sevilla, J. M., Pineda, T., Bl\u00e1zquez, M. & Gonzalez-Rodriguez, J. Study of the electro-oxidation of a recreational drug GHB (gamma hydroxybutyric acid) on a platinum catalyst-type electrode through chronoamperometry and spectro-electrochemistry. J. Electroanal. Chem. 766, 141\u2013146. https:\/\/doi.org\/10.1016\/j.jelechem.2016.02.005 (2016).","journal-title":"J. Electroanal. Chem."},{"key":"1644_CR20","doi-asserted-by":"publisher","first-page":"110757","DOI":"10.1016\/j.dyepig.2022.110757","volume":"207","author":"S Rodr\u00edguez-Nu\u00e9valos","year":"2022","unstructured":"Rodr\u00edguez-Nu\u00e9valos, S. et al. Colorimetric and fluorescent hydrazone-BODIPY probes for the detection of \u03b3-hydroxybutyric acid (GHB) and Cathinones. Dyes Pigm. 207, 110757. https:\/\/doi.org\/10.1016\/j.dyepig.2022.110757 (2022).","journal-title":"Dyes Pigm."},{"key":"1644_CR21","doi-asserted-by":"publisher","first-page":"133043","DOI":"10.1016\/j.snb.2022.133043","volume":"377","author":"E Garrido","year":"2023","unstructured":"Garrido, E. et al. Strip-based lateral flow-type indicator displacement assay for \u03b3-hydroxybutyric acid (GHB) detection in beverages. Sens. Actuators B. 377, 133043. https:\/\/doi.org\/10.1016\/j.snb.2022.133043 (2023).","journal-title":"Sens. Actuators B"},{"key":"1644_CR22","doi-asserted-by":"publisher","first-page":"36228","DOI":"10.1016\/j.snb.2024.136228","volume":"418","author":"A Jantasin","year":"2024","unstructured":"Jantasin, A., Worakul, T., Surawatanawong, P., Saetear, P. & Ruangsupapichat, N. Novel aminoquinazolinone-based colorimetric chemosensor for highly selective recognition of gamma-hydroxybutyric acid (GHB) in spiked beverages. Sens. Actuators B. 418, 36228. https:\/\/doi.org\/10.1016\/j.snb.2024.136228 (2024).","journal-title":"Sens. Actuators B"},{"key":"1644_CR23","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","volume":"92","author":"W Pena-Pereira","year":"2020","unstructured":"Pena-Pereira, W., Wojnowski, F. & Tobiszewski, M. AGREE\u2014Analytical greenness metric approach and software. Anal. Chem. 92, 10076\u201310082. https:\/\/doi.org\/10.1021\/acs.analchem.0c01887 (2020).","journal-title":"Anal. Chem."},{"key":"1644_CR24","doi-asserted-by":"publisher","first-page":"123418","DOI":"10.1016\/j.saa.2023.123418","volume":"304","author":"MA Algarni","year":"2024","unstructured":"Algarni, M. A. et al. Novel spectrofluorometric method utilizing functionalized carbon quantum Dots for determining Histamine levels in nasal secretions: implications for allergic rhinitis. Spectrochim Acta Part. A. 304, 123418. https:\/\/doi.org\/10.1016\/j.saa.2023.123418 (2024).","journal-title":"Spectrochim Acta Part. A"},{"key":"1644_CR25","unstructured":"ICH Q2 (R1). Validation of Analytical Procedures: Text and Methodology. International Conference on Harmonization. (2005)."},{"key":"1644_CR26","doi-asserted-by":"publisher","first-page":"125123","DOI":"10.1016\/j.saa.2024.125123","volume":"325","author":"S Ramzy","year":"2025","unstructured":"Ramzy, S., Althobaiti, Y. S. & Almalki, A. H. Eco-friendly second derivative synchronous fluorescence spectroscopic method for simultaneous determination of Rosuvastatin and Ezetimibe in pharmaceutical capsules. Spectrochim Acta Part. A. 325, 125123. https:\/\/doi.org\/10.1016\/j.saa.2024.125123 (2025).","journal-title":"Spectrochim Acta Part. A"},{"key":"1644_CR27","doi-asserted-by":"publisher","first-page":"100067","DOI":"10.1016\/j.greeac.2023.100067","volume":"6","author":"AH Akabari","year":"2023","unstructured":"Akabari, A. H. et al. Simultaneous Estimation of Fimasartan potassium trihydrate and Atorvastatin calcium with greenness assessment using HPLC and UV spectrophotometric methods. Green. Anal. Chem. 6, 100067. https:\/\/doi.org\/10.1016\/j.greeac.2023.100067 (2023).","journal-title":"Green. Anal. Chem."},{"key":"1644_CR28","doi-asserted-by":"publisher","first-page":"100237","DOI":"10.1016\/j.greeac.2025.100237","volume":"13","author":"VA Rabadiya","year":"2025","unstructured":"Rabadiya, V. A., Shah, N. & Akabari, A. H. Eco-friendly and stability-indicating HPTLC method for the estimation of carvedilol in pharmaceutical dosage forms: A greenness assessment using NEMI scale, AGREE, and white analytical chemistry. Green. Anal. Chem. 13, 100237. https:\/\/doi.org\/10.1016\/j.greeac.2025.100237 (2025).","journal-title":"Green. Anal. Chem."},{"key":"1644_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s44371-024-00067-x","volume":"2","author":"AH kabari","year":"2025","unstructured":"kabari, A. H. et al. Analytical quality by design (AQbD) methodology for concurrent determination of perindopril erbumine and moxonidine hydrochloride using RP-HPLC with an eco-friendly evaluation. Discov. Chem. 2, 1. https:\/\/doi.org\/10.1007\/s44371-024-00067-x (2025).","journal-title":"Discov. Chem."},{"key":"1644_CR30","doi-asserted-by":"publisher","first-page":"bmae038","DOI":"10.1093\/chromsci\/bmae038","volume":"63","author":"AH Akabari","year":"2025","unstructured":"Akabari, A. H. et al. Stability-Indicating TLC-Densitometric and HPLC methods for simultaneous determination of teneligliptin and Pioglitazone in pharmaceutical dosage forms with eco-friendly assessment. J. Chromatogr. Sci. 63, bmae038. https:\/\/doi.org\/10.1093\/chromsci\/bmae038 (2025).","journal-title":"J. Chromatogr. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01644-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01644-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01644-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T17:41:54Z","timestamp":1752774114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01644-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1644"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01644-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This work was approved by the Committee of Research Ethics in the Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}}],"article-number":"25939"}}